FDA clears blood test to aid evaluation for Alzheimer's disease

Related Stories

• Fasset, which offers stablecoin-powered banking services across Asia and other emerging markets, raised $68M at a $1B valuation, after raising $51M in May
• Chinese EV maker XPeng says its robotics business raised $900M+ led by IDG and Gaorong Ventures at a $6.3B valuation, with Tencent and Alibaba participating
• Filing: Shein will debut on the Hong Kong exchange on Sept. 1, seeking up to $1.8B in its IPO with Goldman Sachs, Morgan Stanley, and JPMorgan as joint sponsors
• Filing: Shein will debut on the Hong Kong exchange on September 1, seeking up to $1.8B in an IPO at a $27B valuation, a fraction of its $100B valuation in 2022
• Rundoo, a provider of AI-powered business operations software for independent supply stores, raised a $30M Series B led by Battery Ventures